96 related articles for article (PubMed ID: 23714368)
1. FOXO6 promotes gastric cancer cell tumorigenicity via upregulation of C-myc.
Qinyu L; Long C; Zhen-dong D; Min-min S; Wei-ze W; Wei-ping Y; Cheng-hong P
FEBS Lett; 2013 Jul; 587(14):2105-11. PubMed ID: 23714368
[TBL] [Abstract][Full Text] [Related]
2. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
3. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
4. BRD4 promotes gastric cancer progression through the transcriptional and epigenetic regulation of c-MYC.
Ba M; Long H; Yan Z; Wang S; Wu Y; Tu Y; Gong Y; Cui S
J Cell Biochem; 2018 Jan; 119(1):973-982. PubMed ID: 28681984
[TBL] [Abstract][Full Text] [Related]
5. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
Ho JS; Ma W; Mao DY; Benchimol S
Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway.
Buchholz M; Schatz A; Wagner M; Michl P; Linhart T; Adler G; Gress TM; Ellenrieder V
EMBO J; 2006 Aug; 25(15):3714-24. PubMed ID: 16874304
[TBL] [Abstract][Full Text] [Related]
7. [Effects of FoxO6 on proliferation and invasion of colorectal cancer cells].
Fu Q; Cheng J; Zhang JD; Zhang YL; Chen XB; Xie JG; Luo SX
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):369-375. PubMed ID: 32482025
[No Abstract] [Full Text] [Related]
8. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc.
Wang LG; Liu XM; Fang Y; Dai W; Chiao FB; Puccio GM; Feng J; Liu D; Chiao JW
Int J Oncol; 2008 Aug; 33(2):375-80. PubMed ID: 18636159
[TBL] [Abstract][Full Text] [Related]
9. FoxO6 inhibits cell proliferation in lung carcinoma through up-regulation of USP7.
Hu HJ; Zhang LG; Wang ZH; Guo XX
Mol Med Rep; 2015 Jul; 12(1):575-80. PubMed ID: 25695151
[TBL] [Abstract][Full Text] [Related]
10. Myc-mediated transcriptional repression by recruitment of histone deacetylase.
Kurland JF; Tansey WP
Cancer Res; 2008 May; 68(10):3624-9. PubMed ID: 18483244
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects.
Marshall GM; Gherardi S; Xu N; Neiron Z; Trahair T; Scarlett CJ; Chang DK; Liu PY; Jankowski K; Iraci N; Haber M; Norris MD; Keating J; Sekyere E; Jonquieres G; Stossi F; Katzenellenbogen BS; Biankin AV; Perini G; Liu T
Oncogene; 2010 Nov; 29(44):5957-68. PubMed ID: 20697349
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc.
Pawar SA; Szentirmay MN; Hermeking H; Sawadogo M
Oncogene; 2004 Aug; 23(36):6125-35. PubMed ID: 15208653
[TBL] [Abstract][Full Text] [Related]
13. The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer.
Wang J; Elahi A; Ajidahun A; Clark W; Hernandez J; Achille A; Hao JH; Seto E; Shibata D
Cancer Biol Ther; 2014 Sep; 15(9):1198-207. PubMed ID: 24919179
[TBL] [Abstract][Full Text] [Related]
14. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
15. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
Cosgrave N; Hill AD; Young LS
J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
17. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter.
Bouchard C; Dittrich O; Kiermaier A; Dohmann K; Menkel A; Eilers M; Lüscher B
Genes Dev; 2001 Aug; 15(16):2042-7. PubMed ID: 11511535
[TBL] [Abstract][Full Text] [Related]
18. Isoflurane preconditioning protects hepatocytes from oxygen glucose deprivation injury by regulating FoxO6.
Zhong Y; Hu X; Miao L
J Biosci; 2019 Dec; 44(6):. PubMed ID: 31894125
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells.
Li H; Wu X
Biochem Biophys Res Commun; 2004 Nov; 324(2):860-7. PubMed ID: 15474507
[TBL] [Abstract][Full Text] [Related]
20. PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.
Zippo A; De Robertis A; Serafini R; Oliviero S
Nat Cell Biol; 2007 Aug; 9(8):932-44. PubMed ID: 17643117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
